Woodline Partners LP Bristol Myers Squibb CO Transaction History

Woodline Partners LP

$11 Billion
Q3 2024

A detailed history of Woodline Partners LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Woodline Partners LP holds 778,156 shares of BMY stock, worth $45.9 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

778,156

Previous 763,172 1.96%

Holding current value

$45.9 Million

Previous $31.7 Million 27.06%

% of portfolio

0.37%

Previous 0.32%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $594,265 - $775,422	14,984 Added 1.96%	778,156 $40.3 Million
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $244,800 - $322,285	-6,082 Reduced 0.79%	763,172 $31.7 Million
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $7,484 - $8,486	156 Added 0.02%	769,254 $41.7 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $25.8 Million - $30.8 Million	531,618 Added 223.86%	769,098 $39.5 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $2.16 Million - $2.41 Million	37,280 Added 18.62%	237,480 $13.8 Million
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $3.91 Million - $4.34 Million	-61,413 Reduced 23.47%	200,200 $12.8 Million
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $193,384 - $219,341	2,943 Added 1.14%	261,613 $18.1 Million
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $632,070 - $748,460	-9,230 Reduced 3.45%	258,670 $18.6 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $75,696 - $44.7 Million	-582,280 Reduced 68.49%	267,900 $19 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $33 Million - $36.4 Million	454,610 Added 114.93%	850,180 $65.5 Million
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $13.1 Million - $14.2 Million	-211,261 Reduced 34.81%	395,570 $26.4 Million
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $36 Million - $40.5 Million	606,831 New	606,831 $38.3 Million
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $63.7 Million - $72.2 Million	-1,103,742 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $63.4 Million - $70.2 Million	1,103,742 New	1,103,742 $66.5 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $25.7 Million - $37.3 Million	-552,945 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $27.2 Million - $35.5 Million	552,945 New	552,945 $35.5 Million

Others Institutions Holding BMY

# of Institutions

2,602

Shares Held

1.46B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Bristol Myers Squibb CO Transaction History